Data / Form D filings / PROLOR Biotech, Inc.
PROLOR Biotech, Inc.: Form D filings
PROLOR Biotech, Inc., a biotechnology company in Nes-Ziona, filed 2 Form D notices with the SEC between 2009 and 2010. The latest, on March 25, 2010, reports $24.4 million sold of a $24.4 million offering to 18 investors.
Find out what PROLOR Biotech, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3 SAPIR STREET, WEIZMANN SCIENCE PARK, Nes-Ziona, 74140
- Phone
- (866) 644-7811
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Nevada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1268659
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 25, 2010 | New notice | $24,399,991 | $24,399,991 | $0 | 18 | Mar 17, 2010 | sec.gov |
| Aug 6, 2009 | New notice | $10,000,000 | $2,000,000 | $8,000,000 | 4 | Jul 23, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Marian Gorecki | Director | |
| Phillip Frost | Director | |
| Steven D. Rubin | Director | |
| Shai Novik | Executive Officer, Director | |
| Abraham Havron | Executive Officer, Director | |
| Steve Schaeffer | Executive Officer | |
| Jane H. Hsiao | Director | |
| Fuad Fares | Executive Officer, Director | |
| Adam D. Stern | Director |
Every Form D from the week of Mar 22, 2010 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what PROLOR Biotech, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.